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Bacteriological response is generally considered the best criterion for assessing the effi-
cacy of chemotherapy in patients with pulmonary tuberculosis. The bacteriological methods
most commonly used are examination of sputum smears for tubercle bacilli, culture of bacilli
from sputum specimens, and drug-sensitivity tests on positive cultures. Culture examination,
though more sensitive than smear examination in detecting tubercle bacilli, is time-
consuming and economically impracticable as a routine method in most developing countries.
A study was therefore undertaken at the Tuberculosis Chemotherapy Centre, Madras, to
determine the relative value of smear examination and culture examination in predicting the
outcome of treatment and assessing the efficacy of chemotherapeutic regimens in 515 patients
(all with bacteriologically confirmed disease and isoniazid-sensitive organisms on admission)
receiving isoniazid, alone or with sodium PAS. The results showed that the value of smear
examination of overnight sputum specimens at monthly intervals closely approached that
of culture examination in assessing the progress of the patients, the percentages of correct
predictions by smear and by culture being of the same order. Smear examination was
slightly less effective than culture examination in detecting differences in the efficacies of
regimens, but it has been estimated that this disadvantage can usually be compensatedfor by
increasing the study population by about 20 %.
In studies of the chemotherapy of pulmonary
tuberculosis undertaken at the Tuberculosis Chemo-
   therapy Centre, Madras, the progress of patients
has been assessed mainly on the results of sputum
cultures for tubercle bacilli. However, culture
facilities are either very limited or unavailable in
most tuberculosis clinics in developing countries.
The present paper therefore attempts to study the
efficacy of the simple method of sputum smear
examination for tubercle bacilli, relative to that of
culture examination (and isoniazid-sensitivity tests),
in assessing the progress of patients receiving
Chemotherapy and in classifying their response to
treatment. The comparisons are based on the ability,
* From the Tuberculosis Chemotherapy Centre, Madras-
31. India. The Centre is under the joint auspices of the Indian
Council of Medical Research, the Madras State Government,
the World Health Organization and the Medical Research
Council of Great Britain.
d ring treatment, of these methods to predict the
utcome at the end of one year of chemotherapy.
The patients for these comparisons have been drawn
fr m the first 3 chemotherapy studies under-
taken at the Centre (Tuberculosis Chemotherapy
Ce tre, Madras, 1959, 1960, 1963). In these studies,
five regimens, ranging in therapeutic efficacy (as
mea ured by the proportion of patients showing a
favourable response, assessed mainly by strict
bacteriological criteria) from about 45 % to 90 %,
had been investigated.
PATIENTS
In this report, 532 patients, who were included in
the main analysis of three chemotherapy studies
(Tuberculos s Chemotherapy Centre, Madras, 1959,
1960, 1963), have been considered. All were aged
12 years or more, had pulmonary tuberculosis
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confirmed by culture examination, had had no
previous chemotherapy (except 18 (3%) who had
received up to two weeks of chemotherapy), and
were excreting soniazid-sensitive tubercl bacilli on
admission to treatment. They were prescribed
isoniazid plus p-aminosalicylic acid (sodium PAS) or
one of four regimens of isoniazid alone for 12 months
(see footnote to Table 5).
Seventeen patients have been excluded from all
the analyses in the present report because their
response to the initially prescribed chemotherapy
could not be assessed, eight because they died of
non-tuberculous conditions and nine because their
chemotherapy was changed on account of drug
toxicity. Of the remaining 515, who form the subject
of this report, 9 died of tuberculosis and 40 had
the initially prescribed chemotherapy changed on
account of serious radiographic or clinical deteriora-
tion. These 49 patients have been classified as having
an unfavourable response to treatment and included
in all the analyses up to the time of death or change
of chemotherapy.
lNVESTIGATIONS DURING TREATMENT
All the patients had routine monthly examinations
at the Centre which included a chest radiograph
and sputum examination. At the end of each month
of treatment, they were asked to produce two col-
lection specimens of sputum. In addition, from
three months onwards, when it was anticipated
that some of the patients would have difficulty in
expectorating, a pair of laryngeal swabs was taken
from all patients at each monthly examination. The
sputum specimens were examined for the presence
of tubercle bacilli both by smear and by culture, and
the laryngeal swabs by culture only. An isoniazid-
sensitivity test was set up on one positive culture, if
available, at each monthly examination.
Methods of obtaining specimens
Collection specimens of sputum. The patient was
given a sterile screw-capped McCartney bottle (1 oz 1)
to take home and was instructed to expectorate into
it until it was nearly full. On the following morning,
the bottle was handed in at the laboratory; the
specimen was thus material collected overnight and
sometimes over 24 hours.
Laryngeal swab specimens. A pair of swabs was
obtained at the Centre from each patient as de-
scribed by Velu, Narayana & Subbaiah (1961).
1 1 fluid ounce ~ 28 ml.
Bacteriological procedures
Direct smear examination of sputum specimens. A
new glass slide was used for the preparation of each
smear. Purulent or, failing this, mucoid material or
any deposit in the sputum was selected for examina-
tion. The whole smear was examined by fluores-
cence microscopy (Holst, Mitchison & Radha-
krishna, 1959) and was reported as positive if it
contained a minimum of four acid-fast bacilli of
typical morphology.
Culture f sputum specimens and laryngeal swab
specimens. From each sputum specimen and from
each pair of laryngeal swabs (processed as one
specimen), cultures were set up on Löwenstein-
Jensen medium without potato starch (Tuberculosis   
Chemotherapy Centre, Madras, 1959), and examined
weekly for 8-9 weeks; they were reported as negative
if no growth was present by that time.
Sensitivity tests. Test  of sensitivity to isoniazid
were set up on Löwenstein-Jensen medium slopes
containing concentrations of isoniazid of 0.2, 1, 5
and 50 µg/ml, as well as on a drug-free control
slope, by inoculating approximately 0.01 mg (moist
weight) of tubercle bacilli (Tuberculosis Chemo-
therapy Centre, Madras, 1959). A culture isolated
during treatment was classified as isoniazid-resistant
if it yielded a growth of 20 colonies or more on the
slope containing 0.2 µg/ml.
DEFINITIONS OF FAVOURABLE AND UNFAVOURABLE
RESPONSE TO TREATMENT
Patients with a favourable response to treatment
are defined as those who yielded only negative cul-
tures (usually 7-9) at least at the last three monthly
examinations, that is, at 10, 11 and 12 months. In    
addition, 21 (4%) patients who yielded only one
positive culture at 10, 11 or 12 months following at
least three consecutive monthly examinations at
which all cultures were negative have also been
regarded as having had a favourable response for
reasons reported earlier (Velu et al., 1960, 1961;
Devadatta et al., 1961a; Dawson et al., 1966 2.
Patients with an unfavourable response to treat-
ment are defined as (a) those who never had all 
cultures negative at three consecutive monthly
examinations or (b) those who had a total of two
or more positive cultures at the last three monthly
examinations following culture negativity at three or
2 See article on page 533 of this issue.
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more consecutive monthly examinations or (c) tho e
who had had their chemotherapy changed owing to
serious radiographic or clinical deterioration or (d)
those who died of tuberculosis.
It will be noted that these definitions do not
depend on the results of smear examination of
sputum specimens.
RESULTS
Although five regimens with different levels of
therapeutic effectiveness were investigated, only the
amalgamated results have been presented in Tables
1 to 4; the findings in the individual treatment series
are briefly discussed on page 578.
Prognosticvalue of smear, culture and isoniazid-
sensitivity examinations of one sputum specimen
during treatment
Table 1 compares the value of smear examination,
culture examination and isoniazid-sensitivity tests
in predicting favourable response to treatment. The
analysis is based on the results obtained with one
sputum specimen each month. In order that the com-
parisons between the three methods are based on
the same population, only those patients who had
both smear and culture results available on the
same specimen, together with an isoniazid-sensitivity
test result at that month if the culture was positive,
have been included in the analysis.
Considering first the results of smear examination,
65% of 198 patients with a positive smear at one
month had a favourable response at one year, as
compared with 82% of 282 patients with a negative
smear. The corresponding proportions at two months
were 54 % of 125 and 82% of 365 patients. Thus,
  in the first 2 months, smear examination was not
  of much prognostic value. However, this value
increased in subsequent months. Thus, 33% of 108
patients with a positive smear at 3 months as com-
pared with 86% of 375 with a negative smear had a
favourable response at one year; the corresponding
proportions at 6 months were 3 % of 70 and 88 % of
415, and these remained fairly stationary for the rest
of the year, the proportions at 12 months being 0%
of 49 and 91% of 399, respectively. An indica-
tion of the gradual increase from month to month
in the prognostic value of smear examination is
provided by the trend observed in the percen age
of correct predictions, 1 when the results of smear
examination at each month are used to predict
the outcome at the end of one year of treatment.
This proportion was 62% at 1 month, 82% at
3 months, 90% at 6 months, 89% at 9 months
and 92 % at 12 months.
Culture examination in the first 2 months of
treatment was also not of much prognostic value.
However, its value, like that of smear examination,
increased subsequently. Thus 10% of 98 patients
with a positive culture at 6 months had a favourable
response at one year, as compared with 93 % of 387
patients with a negative culture; the corresponding
proportions at 12 months were 6 % of 69 and 95 %
of 379. The proportion of correct predictions 1 was
47 % at 1 month, 78 % at 3 months, 92 % at 6 months,
94 % at 9 months and 95 % at 12 months.
Considering next the results of isoniazid-sensitivity
tests, 18 % of 28 patients with a resistant culture at
one m th had a favourable response at one year,
as compared with 78 % of 452 patients with an isonia-
zid-sensitive or a negative culture. The corresponding
proportions at two months were 12 % of 65 and 84 %
of 425 patients. Thus, even in the early months of
treatment, the isoniazid-sensitivity test was of mode-
rate prognostic value. Thereafter, its value increased
further. Thus, 7% of 95 patients with a resistant
culture at 6 months had a favourable response at
one year, as compared with 93% of 390 with a
sensitive or negative culture, and at 12 months the
corresponding proportions were 2% of 65 and 95%
of 383. The proportion of correct predictions 2 was
78 % at 1 month, 84 % at 2 months, 87 % at 3 months,
93 % at 6 months, 94 % at 9 months and 95 % at
12 months.
On comparing the prognostic value of smear
examination with that of culture examination, it is
seen that neither examination is very satisfactory
in the early months of treatment; thus, at three
months, predictions based on smear results would
have been correct in 82% of the patients, the cor-
responding figure for culture results being 78%.
At subsequent months, both types of examination
yielded very satisfactory results–for example, the
1 This figure is derived for each month by adding the
number of patients with a negative result at that month and
a favourable response at one year to the number with a
positive result at that month and an unfavourable response
at one year, and expressing the sum as a proportion of the
total patients assessed. For example, considering smear
results at three months, the figures are 323 and 72, respectively,
resulting in 395 correct predictions out of a total of 483, that
is, 82 % of correct predictions.
2 This figure is derived for each month by adding the
number of patients with a negative or an isoniazid-sensitive
culture at that month and a favourable response at one year
to the number with an isoniazid-resistant culture at that
month and an unfavourable response at one year, and
expressing the sum as a proportion of the total patients
assessed.
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TABLE 1
FAVOURABLE RESPONSE AT ONE YEAR RELATED TO RESULTS OF SMEAR, CULTURE AND ISONIAZID-SENSITIVITY
T E S T S  O N  O N E  S P U T U M  S P E C I M E N .  A T  M O N T H L Y  I N T E R V A L S  D U R I N G  T R E A T M E N T
Culture
Positive Negative Positive Negative
lsoniazid sensitivity
Sensitive
Resistant or culture-
negative
78
241 249
142 223
59 90
66 84
78
87 396
13 346
15 87
87
89 90
92 93
98 387
10 359
10 93
92
95 390
7 362
7 93
93
93 94
94 95
78 387 75 390
3 363 1 365
4 94 1 94
94 94
95 95
 
Smear
Total
patients
in
analysis a
480
1
2
3
4
5
6
7
8
9
12
Total patients
Favourable response No.
%
% correctly predicted 62
490Total patients
Favourable response No.
%
% correctly predicted 73
Total patients
Favourable response No.
%
483
% correctly predicted 82
484Total patients
Favourable response No.
%
% correctly predicted 85
487Total patients
Favourable response No.
%
% correctly predicted
Total patients
Favourable response No.
%
% correctly predicted 90
476Total patients
Favourable response No.
%
61 415
5 360
8 87
% correctly predicted 87
470Total patients
Favourable response No.
% correctly predicted 90
Total patients
Favourable response No.
%
89% correctly predicted
Total patients
Favourable response No.
%
448
% correctly predicted 92
a See text on preceding page.
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proportion of correct predictions at six months was
90 % with smear results and 92 % with culture results;
nevertheless, the prognostic value of culture was
consistently better than that of smear. For assessing
the statistical significance of this difference, it is
convenient to present the results as in Table 2. This
table shows that, at four months, correct predictions
were made by both smear and culture results for
396 of 484 patients and incorrect predictions by both
in 40, so that predictions based on smear and those
based on culture were equally efficient or inefficient
in 436 (90%) of the patients. Of the remaining
48 (10%) patients, 14 were correctly predicted by
smear but incorrectly by culture and, conversely,
   34 were correctly predicted by culture and incor-
rectly by smear; this difference is statistically signifi-
cant (P<0.01). The findings at subsequent months
also showed a consistent and statistically significant
benefit to the culture examination. However, this
benefit was usually of the order of only 5% and is,
to a certain extent, offset by the fact that cultures
are likely to become contaminated; further, it always
takes much longer to obtain culture results–accord-
ing to the procedure used in this laboratory, up to
nine weeks-as compared with smear results, which
usually can be obtained the same day.
On comparing next the prognostic value of culture
examination with that of the isoniazid-sensitivity test,
the latter was found to be uniformly better in the
early months of treatment; thus, the difference in
the magnitude of correct predictions was 31% at
1 , 18% at 2 months, 9% at 3 months, and
1% at most of the subsequent months (Table 1).
(However, according to the procedure used in this
laboratory, it takes four weeks after a culture has
become posit ve for the sensitivity test result to
become available.) An assessment of the statistical
significance of this difference must of necessity be
confined to patients who produced a positive
culture. At one month, there were 362 patients with
positive cultures; both types of examination yielded
c rect predic ions in 23 patients and incorrect pre-
dictions in 5 (not tabulated here). In the remaining
334 patients, the outcome was correctly predicted
by culture results in 91 and by isoniazid-sensitivity
sults  243, the difference being highly significant
statistically (P<0.001). The corresponding diffe-
rences at two months and three months were also
highly significant (P<0.001). However, at four
months discrepant predictions were obtained for
only 16 patients; the prediction based on culture
was correct in 4 cases and that based on isoniazid-
sensitivity in 12, the difference just attaining statis-
tical significance (P ~ 0.05). At subsequent months,
none of the differences was statistically significant.
It may be concluded that the examination by
smear of one overnight specimen of sputum at
monthly intervals is of great prognostic value, it
being possible to predict correctly from four months
onwards the outcome of treatment in at least 85%
of the patients. Examination by culture increases
this proportion to at least 89%, the increase being
TABLE 2
C O M P A R I S O N  O F  T H E  P R O G N O S T I C  V A L U E  O F  S M E A R  E X A M I N A T I O N  A N D  C U L T U R E  E X A M I N A T I O N
Correct
Incorrect
Correct
Incorrect
Total
O F  O N E  S P U T U M  S P E C I M E N ,  A T  M O N T H L Y  I N T E R V A L S  D U R I N G  T R E A T M E N T
Correct
Incorrect
Incorrect
Correct
c 2 a
P
4
No. %
396 8 2
40 8
14 3
34 7
Months after start of treatment
5 6
No. % No. %
415 8 5 424 8 7
28 6 27 6
11 2 11 2
33 7 23 5
437 100 485 100
11.00 4.24
<0.001 <0.05
7 8
No. % No. %
406 8 5 417 8 9
21 4 21 4
10 2 6 1
39 8 26 6
476 9 9
17.16
470 100
12.50
9 12
No. % No. %
413 8 9 407 9 1
24 5 19 4
3 1 5 1
25 5 17 4
465 100 448 100
17.29 6.55
< 0 . 0 0 1   ~  0 . 0 1
a Based on the third and fourth rows of figures and having one degree of freedom.
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statistically significant. No further benefit is derived
after four months (in terms of correct predictions)
by the performance of an isoniazid-sensitivity test.
However, in the early months of treatment, the
proportion of correct predictions can be significantly
increased by considering the results of isoniazid-
sensitivity tests.
Comparison of the prognostic value of smear examina-
tion of one and two sputum specimens during treat-
ment
Since smear examination of one sputum specimen
during treatment was found to be of great prognostic
value from four months onwards, it was decided to
investigate whether the smear examination of an
additional specimen would enhance the value,
particularly at 1, 2 and 3 months. Analyses were
therefore undertaken, along the lines of those in
Table 1, on all patients with smear results on two
sputum specimens at the monthly examination,
irrespective of the availability of culture results.
Analyses, not tabulated here, showed that in the
first 3 months of treatment, prognostication based
on two smears was unsatisfactory as was the case
with one smear. Further, they also showed that
from four months onwards, when the majority of
sputum smears were negative, the prognosis of
one positive smear plus one negative smear was
invariably closer to that of two positive smears
than to that of two negative smears; consequently, in
Table 3, which presents the findings at 4-9 months
and at 12 months, patients have been classified as
having“ at least one positive smear” or “ both
smears negative ”,when considering the prognostic
significance of two smears. These findings show
that, at four months, the proportion of patients
whose response was correctly predicted by con-
sidering the smear result of one specimen was
84%, as compared with 86% by considering the
smear results of two specimens; the corresponding
figures at five months were 87 % and 86 %, respect-
ively; neither of these differences attained statistical
significance. Both at six months and at seven months,
the proportion of correct predictions was signifi-
cantly (although only slightly) greater when based on
smear results of two sputum specimens instead of
one; thus, the proportions were 92% and 90% at
six months (P ~ 0.02), and 90% and 87% at seven
months (P ~ 0.001). At eight months and sub-
sequently, the differences were smaller and were
statistically non-significant.
It may be concluded that, from six months
onwards, the prognostic value of two smear examina-
AND OTHERS
tions each month is slightly greater than that of one
smear examination.
Comparison of the prognostic value of two smears,
one culture and two cultures during treatment
It has been shown that the prognostic value of
culture examination of one sputum specimen during
treatment is slightly greater than that of smear
examination of one specimen from four months
onwards. It has also been shown that the prognostic
value of smear examination of two specimens is
slightly greater than that of one specimen from six
months onwards. It was therefore decided to com-
pare the prognostic value of smear examination of   
two specimens with that of culture examination of
one specimen from six months onwards. This com-
parison is presented in Table 4, which also includes
the results obtained by culture examination of two
specimens. Only patients with both smear and culture
results available on two specimens of sputum at the
monthly examinations have been included in the
analysis. As with smears, the prognosis of one
positive culture plus one negative culture was
invariably closer to that of two positive cultures
than to that of two negative cultures, so that patients
have been classified in the table as having “ at least
one positive culture ”or “ both cultures negative ”,
when considering the prognostic significance of two
cultures.
At six months, the proportion of correct predic-
tions was 92% whether two smears or one culture
formed the basis of prediction. However, both at
seven and at eight months, predictions based on
two smears were correct in 90% of the patients, as
compared wi h 93% in the case of one culture, a
significant difference (P<0.02). The corresponding
proportions were 91% and 94% at nine months
(P ~ 0.02), and 92% and 94% at 12 months (P ~ 0.05).
It may be concluded that, from six months onwards,
the prognostic value of culture examination of one
sputum specimen is slightly but consistently greater
tha tha  of smear examination of two specimens.
On comparing next the prognostic value of culture
examin tion of one sputum specimen with that of
two specimens, little difference was found in the
proportions of correct predictions (Table 4).
Findings in the individual treatment series
The pati nts in the present report received
isoniazid plus sodium PAS (PH) or one of four
regimens of isoniazid alone, namely, HI-1, HI-2, H
and H650 (for details, see footnote to Table 5). It
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FAVOURABLE  RESPONSE  AT  ONE  YEAR  RELATED  TO  THE  RESULTS
OF SMEAR EXAMINATION OF ONE SPUTUM SPECIMEN AND OF TWO SPUTUM SPECIMENS,
A T  M O N T H L Y  I N T E R V A L S  D U R I N G  T R E A T M E N T
4
5
6
7
8
9
12
Total patients
Favourable response No.
%
% correctly predicted
Total patients
Favourable response No.
%
% correctly predicted
Total patients
Favourable response No.
%
% correctly predicted
Total patients
Favourable response No.
%
% correctly predicted
Total patients
Favourable response No.
%
% correctly predicted
Total patients
Favourable response No.
%
Total patients
Favourable response No.
%
% correctly predicted
- -
- -
- -
a See text on opposite page.
was found that the HI-1 and H650 regimens were of
the same order of therapeutic efficacy (Tuberculosis
Chemotherapy Centre, Madras, 1963); this was also
true of the HI-2 and H regimens which were,
however, less effective (Tuberculosis Chemotherapy
Centre, Madras, 1960). The PH regimen was the
most efficacious.
Separate analyses were undertaken for patients
in the PH, HI-1/H650 and HI-2/H series to deter-
mine the extent to which the main conclusions drawn
so fa  may have to be modified by the differences
between the regimens in therapeutic efficacy. Table 5
ummarizes the findings of analyses based on one
sputum specimen collected at monthly intervals
during treatment, from four months onwards. First,
it is s en that both smear and culture are of least
prognostic value in the HI-2/H series, the mean
pro ortion of correct predictions being 83.6% and
89.2%, r spectively, as compared with 89.2% and
95.7 % in the HI-1/H650 series and 92.1% and 94.3 %
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A T  M O N T H L Y  I N T E R V A L S  D U R I N G  T R E A T M E N T
% correctly predicted 90 93
Two cultures
At least
one
positive
Both
negative
93
93
91 290
10 282
11 97
95
94
94
Total
patients in
analysis a
396
393
381
363
359
TABLE 5. COMPARISON OF THE PROGNOSTIC VALUE IN INDIVIDUAL TREATMENT SERIES OF SMEAR EXAMINATION
A N D  C U L T U R E  E X A M I N A T I O N  O F  O N E  S P U T U M  S P E C I M E N  A T  M O N T H L Y  I N T E R V A L S  D U R I N G  T R E A T M E N T
Percentage of correct oredictions
Months after start of treatment
P H
HI-1/H650
HI-2/H
4 5 I 6 7
Smear 88 88 92 92
Culture 89 93 94 95
Smear 89 88 90 85
Culture 94 98 95 95
Smear 76 87 85 81
Culture 84 8 7 8 7 88
8 I 9 10 11 12 Mean
94 94 96 92.1
95 97 95 94.3
90 91 90 89.2
98 9 7 96 95.7
85 82 86 83.6
91 93 92 89.2
a PH: 3.9-5.5 mg/kg body-weight (200 mg for 100-lb (45.4-kg) patient) of isoniazid plus 0.2-0.3 g/kg body-weight of sodium PAS
(10 g for 100-lb patient), daily in two divided doses, for 12 months.
HI-1: 7.8-9.8 mg/kg body-weight (400 mg for 100-lb patient) of isoniazid alone, daily in one dose, for 12 months.
HI-2: 7.8-9.8 mg/kg body-weight (400 mg for 100-lb patient) of isoniazid alone, daily in two divided doses, for 12 months.
H: 3.9-5.5 mg/kg body-weight (200 mg for 100-lb patient) of isoniazid alone, daily in two divided doses, for 12 months.
H650: 12.5-15.2 mg/kg body-weight (850 mg for 100-lb patient) of isoniazid alone, daily in one dose, for 12 months.
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THERAPEUTIC EFFICACIES OF ANTITUBERCULOSIS REGIMENS IN THREE CONTROLLED
STUDIES, AS ASSESSED BY SMEAR RESULTS AND CULTURE RESULTS
Study Treatmentseries a
First
Sanatorium (PH)
Home (PH)
PH
HI-1
Second
HI-2
H
Third H650
Patients with a favourable response
Total
patientsClassification based
on culture results b
No. %
81  73  90
81 67 83
86 78 91
64 47 73
66 38 58
86 38 44
51 37 73
a For details, see footnote to Table 5.
b For details, see page 574.
c For details, see text below.
in the PH series, respectively. Secondly, the contrast
in prognostic value between smear and culture
examinations is smallest in the PH series, the mean
difference in the proportion of correct predictions
being 2.2 % as compared with 6.5 % in the HI-1/H650
series and 5.6% in the HI-2/H series; the differences
in these figures between the PH series and each of
the other two series attain statistical significance
(P<0.02). These findings suggest that the value of
both types of examination, particularly the smear
examination, is adversely affected if the regimen is
of low efficacy and that both are prognostically more
efficient and yield closely similar results if the
regimen is of high efficacy.
Comparison of smear and culture examinations in
assessing the therapeutic efficacies of antitubercu-
losis regimens
At the Centre, the therapeutic efficacy of antituber-
culosis regimens is assessed mainly on the basis of
culture results of sputum specimens collected at 10,
11 and 12 months. It is now proposed to study the
value of similar assessments based solely on smear
results. Such a study would be of special interest to
centres in developing countries with limited or no
culture facilities.
In the following analyses, the definition of
favourable response, based on smear results only, is
“ all smears (usually 7-9) negative at 10, 11 and
12 months ”, and that of unfavourable response is
Classification based
on smear results c
No. %
72 89
69 85
77 90
48 75
43 65
41 48
38 75
“ a  least one positive smear at 10, 11 o 12 months,
or change of chemotherapy owing to serious radio-
graphic or clinical deterioration, or death from
tube culosis ”.The corresponding definitions based
on culture results have been stated on page 574.
Both sets of definitions were applied to patients
in three studies undertaken at the Centre and the
findin s are presented in Table 6. The first study
was a comparison of the efficacy of treatment with
isoniazid plus PAS at home and the same treatment
in sanatorium, for 12 months (Tuberculosis Chemo-
therapy Centre, Madras, 1959). The second was a
comparison of the efficacies of four antitubercu-
losis regimens, three of isoniazid alone and one of
isoniazid plus PAS, in the domiciliary treatment of
pulmonary tuberculosis for 12 months (Tubercu-
losis Chemotherapy Centre, Madras, 1960). In the
third, which was a controlled study of isoniazid
toxicity, only one antituberculosis regimen, namely a
high dosage of isoniazid, was used (Tuberculosis
Chemotherapy Centre, Madras, 1963).
In the first study, 90% of 81 patients treated in
sanatorium were classified, on the basis of culture
results, as having had a favourable response, as
compared with 89% on the basis of smear results.
The corresponding proportions for 81 patients
trea ed at home were 83% and 85%, respectively.
In the second study, the proportions classified as
having had a favourable response on the basis of
culture results were 91% of 86 PH, 73 % of 64 HI-1,
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58 % of 66 HI-2 and 44 % of 86 H patients; the cor-
responding proportions based on smear results were
90%, 75 %, 65% and 48 %, respectively. In the
third study, 73 % of the 51 patients had a favourable
response as assessed by culture results, as compared
with 75 % as assessed by smear results.
Thus, there is not much difference between the
smear assessment and the culture assessment of the
therapeutic efficacy of the regimens. Further analyses
(not tabulated here) showed that, on the average,
the two assessments yielded an identical classification
in 95 % of the patients (range, 92%-99 %). However,
an inspection of the proportions of patients with a
favourable response to the various regimens shows
that the variation from regimen to regimen is greater
for the classification based on culture results than
for that based on smear results. This is reflected by
the range of these proportions, which is 44%-91 %
for the former and 48%-90 % for the latter. This
suggests that the ability to detect differences in
efficacy between regimens is greater with cultures
than with smears. In the Annex (page 586), this
conclusion is confirmed on a larger number of regi-
mens obtained by including three more studies under-
taken at the Centre. It is also shown there that this
shortcoming of a chemotherapy study based on smear
examination alone can usually be offset by a 20%
increase in the number of patients admitted to study.
Applicability of the findings in situations where smear
examination alone is available for diagnostic pur-
poses
All the analyses in this report are based on 515
patients who had at least one positive culture on
admission to treatment and who were excreting
isoniazid-sensitive bacilli (see page 574). However,
not infrequently,unsatisfactory situationsre
encountered where facilities for culture examination
(and sensitivity tests) are not available, and where
the initial diagnosis of tuberculosis is based mainly
on the results of smear examination. It is therefore
of interest to know how the conclusions in the
foregoing pages would be affected in such situations,
since patients without a positive smear would not
be included while those with isoniazid-resistant
organisms (and at least one positive smear) would
not be excluded. In the present instance, there were
43 patients in the former category and 28 in the
latter; on excluding the 43 and including the 28, the
modified population for analysis became 500.
Analyses were undertaken on the modified popula-
tion to compare the prognostic value of smear
examinati n and culture examination of one sputum
specimen at monthly intervals during treatment.
These s owed that, apart from decreasing very
slightly (1 % to 3 %) the proportion of correct pre-
dictions, the changes in the population did not have
any important effect either on the prognostic value
of smear or on that of culture. It therefore seems
r asonable to conclude that the findings in the
present paper are also applicable to situations where
sm ar x mination alone is available for diagnostic
purposes; however, it must be emphasized that this
conclusion is based on data from a clinic where
excretors of acid-fast bacilli of non-tuberculous
origin are uncommon.
DISCUSSION
The progress during treatment of patients with
pulmonary tuberculosis is usually followed by
periodic bacteriological, radiographic and clinical
examinations. In economically favoured countries,
it is possible to prescribe regimens of chemotherapy
which produce a favourable response in virtually
100 % of the patients (Crofton, 1960; Canetti, 1962).
In such situations, despite current practice, it is
obviously not important to follow closely the pro-
gress of patients receiving chemotherapy provided
it is ensured that they are in fact receiving the
prescribed drugs. On the other hand, in developing
countries, regimens which do not produce a favour-
able response in 100% of the patients often have to
be prescribed for economic reasons (Lauckner, 1959;
Canetti, 1962; Tubercle (Lond.), 1963; Fox, 1964).
Under these circumstances, it is important to assess
periodically the progress of patients so that those   
whose disease is not responding to chemotherapy
may be detected as early as possible.
Of the various methods used to follow the pro-
gress of patients, bacteriological assessments are
the most valuable (American Trudeau Society, 1959).
It has been shown at the Centre that the erythrocyte
sedimentation rate is an unsatisfactory measure of
progress, as an elevated rate is compatible with
bacteriologically quiescent disease at the end of a
year of chemotherapy (Tuberculosis Chemotherapy
Centre, Madras, 1959) or at the end of a 2-year
(Devadatta et al., 1961a) or a 4-year (Dawson et
al., 19661) period of follow-up. Also, serial radio-
graphy is of limited value in assessing the progress
of patients since radiographic deterioration–for
instance, an increase in the size of cavities–can occur
1 See article on page 533 of this issue.
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in the presence of persistent bacteriologically
quiescent disease (Devadatta et al., 1961a), and
radiographic improvement is not necessarily asso-
ciated with a favourable bacteriological response
(Devadatta et al., 1961b).
The bacteriological methods most commonly
used are examination of sputum smears for orga-
nisms morphologically resembling tubercle bacilli,
culture examination for tubercle bacilli and tests
of sensitivity to the drugs prescribed. Culture
examination and drug-sensitivity tests take many
weeks to yield results, require more skilled staff,
and are economically not possible as routine methods
    in most tuberculosis clinics in developing countries
at the present time. Moreover, cultures may become
contaminated with other organisms ; this occurred
in 9.1 % of the 11 445 cultures set up during treat-
ment from sputum specimens obtained from the
515 patients who form the subject of this report.
Smear examination has the disadvantage of being
less sensitive than culture examination in detecting
tubercle bacilli (Corper & Cohn, 1933; Andrews &
Radhakrishna, 1959). It is also more likely to pro-
duce false positive results since it is not usually
possible to distinguish tubercle bacilli from other
acid-fast organisms. However, this occurred very
rarely in the present study; thus, of 2098 sputum
specimens examined during treatment which yielded
a positive smear, only 0.1% were subsequently
found to be due to acid-fast saprophytes. Another
disadvantage is that a smear-positive culture-
negative result would be regarded (often wrongly) as
indicating the presence of viable tubercle bacilli if
culture examination is not undertaken (Tuberculosis
   Chemotherapy Centre, Madras, 1959; Great Britain,
Medical Research Council, 1962); in this study, of
the 2098 sputum specimens with a positive smear,
7.1% yielded a negative culture.
Smear examination, however, does not need
complicated laboratory facilities, is easy to perform,
and results can be obtained on the same day that
specimens are submitted to the laboratory; further,
under Indian conditions, it is approximately 10 times
less expensive than culture examination and 20 times
less expensive than a sensitivity test to a single drug
(E. M. Mackay-Scollay, quoted by Fox, 1964). It was
decided, therefore, to compare the value of smear
examination with that of culture examination and
isoniazid-sensitivity tests in assessing the progress
of patients receiving chemotherapy. The smears were
examined by fluorescence microscopy; this method
yields at least as many positive results as the Ziehl-
Neelsen method, no more false positives, and has
the advantage of a very great saving of time in the
p epar ti n and examination of smears (Holst,
Mitchison & Radhakrishna, 1959).
The findings in the present study are based on the
results of smear and culture examination of sputum
specimens collected at monthly intervals from
515 patients receiving isoniazid, either alone or
in combination with PAS; all 515 patients had
acterio ogically confirmed pulmonary tuberculosis
wi h isoniazid-sensitive organisms on admission
to treatment. The results revealed that, from four
mo ths onwards, the examination by smear of one
sputum specim n per month is a very valuable
method of assessing the progress of patients receiving
chem the apy. For example, 97 % of 70 patients with
a positive smear result at six months had an un-
favourable response at one year and 88 % of 415 with
a negative smear result had a favourable response.
(The r sponse to treatment was classified as favour-
able or unfavourable, mainly on the basis of culture
results of a total of 7-9 sputum specimens, obtained
at 10, 11 and 12 months.) If the smear result at
six month  had been used to predict the response
to treatment, correct predictions would have resulted
fo  90 % of the patients, and this proportion remained
fairly constant for the rest of the year. Examination
by culture of one sputum specimen was of slightly
more prognostic value. Thus, if the results of one
culture examination at six months had been used to
predict th  outcome of treatment, correct predictions
would have resulted for 92% of the patients. How-
ever, in situations where sputum conversion occurs
unusual y late–there is evidence that this happens
in Hong Kong (British Tuberculosis Association/
Hong Kong Tuberculosis Treatment Services, 1964)
–-the v lue of both methods of examination at six
months in predicting the outcome at the end of one
year of chemotherapy might be less.
The close agreement between predictions based
on smear nd culture examinations can be under-
stood by considering the changes in the bacterial
population in any patient receiving chemotherapy.
Thus, if the disease is responding, the sputum first
becomes negative on smear examination because of a
decrease in the bacterial population and then
n gative on culture examination, the disease even-
tually attaining bacteriological quiescence. On the
other hand, if the disease stops responding to the
ch motherapy, the sputum remains positive, or
eventually becomes positive, on smear examination
because of an increase in the bacterial population.
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Furthermore, the frequency of smear-positive culture-
negative results and of acid-fast saprophytes–the
two main causes of false positive results on smear
examination-was not high among the specimens
in this study.
Culture examination of two sputum specimens at
monthly intervals did not prove to be of greater
prognostic value than that of one specimen. How-
ever, with a contamination rate of 9 %, the examina-
tion of two specimens instead of one would sub-
stantially reduce the number of patients with no
information available on account of contaminated
cultures. Isoniazid-sensitivity tests increased the
prognostic value of positive cultures during the first
4 months of treatment. However, this benefit is
not of much practical value because it might take
one month after isolation of a positive culture to
obtain the isoniazid-sensitivity result. After four
months of treatment, no benefit was derived by
considering the results of isoniazid-sensitivity tests,
the explanation for this finding being that nearly
all positive cultures obtained in later months from
patients receiving chemotherapy containing isoniazid
are resistant to that drug (Tuberculosis Chemo-
therapy Centre, Madras, 1959, 1960, 1963; East
African/British Medical Research Council Isoniazid
Investigation, 1960; Selkon et al., 1964).
This study has shown that it is possible to draw
accurate conclusions regarding the efficacies of
antituberculosis regimens from controlled trials,
even if sputum specimens are examined by smear
only instead of by culture. However, in such trials,
the likelihood of detecting differences in efficacy
between regimens would be slightly decreased, a
disadvantage which can usually be offset by a
20% increase in the number of patients admitted
to study. These findings suggest that it would
be inappropriate not to c nsider controlled chemo-
therapy studies in developing countries merely
because facilities for culturing tubercle bacilli are
very limited. Such countries usually have large
numbers of tuberculous patients and, provided an
efficient smear service can be set up, accurate con-
clusions can be drawn from controlled studies in
which smear examination only is undertaken during
treatment, although a slightly larger number of
patients would have to be admitted. Even in these
circumstances, it would be very desirable to under-
take culture and drug-sensitivity examinations on
sputum specimens obtained from patients before
admission to the study. If facilities for quick and
efficient transportation of the sputum specimens are
a ailable, such tests could be arranged either at a
central laboratory in the same country or in a more
developed country. For instance, a central laboratory
in Madras is successfully undertaking cultures and
drug-sensitivity tests on sputum specimens collected
from centres in various parts of India (P. R. J. Ganga-
dharam, personal communication, 1965). Such
tests have also been carried out successfully in Lon-
don on sputum specimens collected from patients
in Hong Kong (Hong Kong Government/British
Medical Research Council Investigation, 1964), and
from patients in Rhodesia (Jean F. Heffernan, per-
so al communication, 1966).
It is concluded that the value of smear examination
of overnight specimens of sputum at monthly inter-    
vals approaches closely that of culture examination
and drug-sensitivity tests in assessing the progress
of tuberculous patients receiving chemotherapy, and
in assessing the therapeutic efficacies of regimens.
SUMMARY
1. Th s paper compares the value of smear
examination for tubercle bacilli of overnight speci-
mens of sputum, month by month, with that of
culture examination and isoniazid-sensitivity tests
in assessing the progress of patients treated with
isoniazid, either alone or with sodium PAS, in three
chemotherapy studies. The comparisons are based on
the ability of these bacteriological methods to predict,
during treatment, the response at the end of 12
months, which was classified as favourable or
unfavourable, mainly on the basis of culture results
at 10, 11 and 12 months.
2. Smear examination, from four months on-
wards, of one sputum specimen was a very valuable
method of assessing the progress of patients receiving
chemotherapy. For example, 97% of 70 patients
with a positive smear at six months had an unfavour-
able response at one year and 88 % of 415 with a
negative smear had a favourable response. If the
results of one smear examination at six months had
been used to predict the outcome of treatment,
correct predictions would have been made in 90%
of the patients.
3. Culture examination of one sputum specimen
was of slightly greater prognostic value than smear
examination from four months onwards. Thus, if
the result of a culture examination at six months
had been used to predict the outcome of treatment,
cor ect predictions would have been made in 92%
of the pati nts. However, this slight advantage,
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which is statistically significant, is partially offset
by the delay in obtaining the results and loss of
information due to contamination.
4. There was evidence suggesting that the value
of smear and culture examinations, particularly the
former, was adversely affected if the regimen was
of low efficacy and that both were prognostically
more efficient and yielded closely similar results
if the regimen was of high efficacy.
5. The prognostic value of smear examination of
two sputum specimens was slightly greater than that
of one specimen, but less than that of culture exami-
nation of one specimen, from six months onwards.
6. Culture examination of two sputum specimens
offered no further benefit over that of one specimen
except in substantially reducing losses due to
contamination.
7. Isoniazid-sensitivity tests were found to increase
the prognostic value of positive cultures during the
first 4 months of chemotherapy only; moreover,
the test results might not become available until as
long as one month after the culture had become
positive.
8. Reliable conclusions could be drawn regarding
the therapeutic efficacies of regimens by considering
the results of smear examination, since the two types
of assessment (smear and culture) yielded, on the
average, identical classifications in 95% of the
patients. However, smear examination was slightly
less sen itive than culture examination in detecting
differences in the therapeutic efficacies of various
antituberculosis regimens; this disadvantage can
usually be offset by admitting about 20% more
patients.
586 S. DEVADATTA AND OTHERS
REFERENCES
American Trudeau Society (1959) Amer. Rev. resp. Dis.,Hoist, E., Mitchison, D. A. & Radhakrishna, S. (1959)
80, 118 Indian J. med. Res., 47, 495
Andrews, R. H. & Radhakrishna, S. (1959) Tubercle
(Lond.), 40,155
British Tuberculosis Association/Hong Kong Tuberculo-
sis Treatment Services (1964) Tubercle (Lond.), 45, 299
Canetti, G. (1962) Tubercle (Lond.), 43, 301
Corper, H. J. & Cohn, M. L. (1933) J. Lab. clin. Med.,
18, 515
Crofton, J. (1960) Brit. med. Bull., 16, 55
Dawson, J. J. Y ., Devadatta, S., Fox, W., Radhakrishna,
S., Ramakrishnan, C. V., Somasundaram, P. R.,
Stott, H. & Velu, S. (1966) Bull. Wld Hlth Org.,
34, 533
Hong Kong Government/British Medical Research
Council Investigation (1964) Tubercle (Lond.), 45, 77
La ckner, J. R. (1959) J. trap. Med. Hyg., 62, 1
Selkon, J. B., Devadatta, S., Kulkami, K. G., Mitchison,
D. A., Narayana, A. S. L., Narayanan Nair, C. &
Ramachandran, K. (1964) Bull. Wld Hlth Org., 31, 273
Snedecor, G. W. (1956) Statistical methods, 5th e ., Ames,
Iowa State College Press, p. 259
Tubercle (Lond.), 1963, 44, 183
Tuberculosis Chemotherapy Centre, Madras (1959)
Bull. Wld Hlth Org., 21, 51
Devadatta, S., Andrews, R. H., Angel, J. H., Bhatia,
A. L., Fox, W., Janardhanam, B., Radhakrishna, S.,
Ramakrishnan, C. V., Subbaiah, T. V. & Velu, S.
(1961a) Bull. Wld Hlth Org., 24, 149
Devadatta, S., Bhatia, A. L., Andrews, R. H., Fox, W.,
Mitchison, D. A., Radhakrishna, S., Ramakrishnan,
C. V., Selkon, J. B. & Velu, S. (1961b) Bull. Wld Hlth
Org., 25, 807
East African/British Medical Research Council Isoniazid
Investigation (1960) Tubercle (Lond.), 41, 83
Fox, W. (1964) Brit. med. J., 1, 135
Great Britain, Medical Research Council, Tuberculosis
Chemotherapy Trials Committee (1962) Tubercle
(Lond.), 43, 201
Tuberculosis Chemotherapy Centre, Madras (1960)  
Bull. Wld Hlth Org., 23, 535
Tuberculosis Chemotherapy Centre, Madras (1963)
Bull. Wld Hlth Org., 28, 455
Velu, S., Andrews, R. H., Angel, J. H., Devadatta, S.,
Fox, W., Gangadharam, P. R. J., Narayana, A. S. L.,
Ramakrishnan, C. V., Selkon, J. B. & Somasundaram,
P. R. (196 1) Bull. Wld Hlth Org., 25, 409
Velu, S., Andrews, R. H., Devadatta, S., Fox, W.,
Radhakrishna, S., Ramakrishnan, C. V., Selkon, J. B.,
Somasundaram, P. R. & Subbaiah, T. V. (1960) Bull.
Wld Hlth Org., 23, 511
Velu, S., Narayana, A. S. L. & Subbaiah, T. V. (1961)
Indian J. Tuberc., 8, 128
Annex
RELATIVE VALUE OF SMEAR AND CULTURE EXAMINATION IN ASSESSING
THE THERAPEUTIC EFFICACIES OF ANTITUBERCULOSIS REGIMENS
The relative value of smear examination and
culture examination in detecting differences in
efficacy between antituberculosis regimens may be
assessed from Table 7, in which the results obtained
with eight regimens used at the Centre since 1956
have been summarized. The details regarding the
first five regimens-namely, PH, HI-1, HI-2, H and
H650–have already been presented (see footnote
to Table 5); those for the last three-namely,
SHTW, TH and P6H/H–are given below:
SHTW. 12.5-16.1 mg/kg body-weight (650 mg
for 100-lb (45.4-kg) patient) of isoniazid in one dose
and a uniform dosage of 1 g of streptomycin,
administered together twice weekly, for 12 months.
TH. 4.6-8.0 mg/kg body-weight (300 mg for
100-lb patient) of isoniazid daily plus 2.3-4.0 mg/kg
body-weight (150 mg for 100-lb patient) of thio-
acetazone daily, in one dose, for 12 months.
P6H/H. A uniform dosage of 200 mg of isoniazid
daily plus 6 g of sodium PAS daily in one dose for
the first 6 months, followed by 6.2-7.7 mg/kg body-
weight (300 mg for 100-lb patient) of isoniazid alone
in one daily dose for the second 6 months.
The dispersion of the percentages of patients
with a favourable response to these eight regimens,
as measured by their variances, is larger for assess-
ments based on cultures than for those based on
smears (see columns headed PC and Ps in Table 7).
For assessing the statistical significance of this
difference, the usual variance ratio test of Fisher
is n t applicable since the variances, being based
on the same set of patients, are not independent.
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TABLE 7
THERAPEUTIC EFFICACIES OF EIGHT
ANTITUBERCULOSIS REGIMENS, AS ASSESSED
BY SMEAR RESULTS AND CULTURE RESULTS
OF SPUTUM SPECIMENS
Regimen a
PH
HI-1
HI-2
H
H650
SHTW
TH
P6H/H
Number of
patients
Classification
based on culture
results b
(Pc)
380 86
64 73
66 58
86 44
143 68
72 94
65 82
68 67
Range
Variance
Standard deviation
Percentage of patients
with a favourable response
44-94 48-90
257.14 193.84
16.0 13.9
Classification
based on smear
results c
(Ps)
88
75
65
48
68
90
83
68
a PH was studied on four occasions, H650 on two and all
the remainder on only one occasion.
b For details, see page 574.
c For details, see page 581.
However, it is evident that, whatever the correla-
tion between the variances of PC and Ps may be,
the sum (Pc+ s) and the difference (PC-Ps) of
the two assessments of efficacy will be uncorrelated
f the variances of Pc and Ps are equal. From this,
Source Degreesof freedom
Between regimens 7
Between patients receiving the same
regimen 931
Total 938
it follows that the statistical significance of the
difference in variances may be assessed by comput-
ing the correlation coefficient, r, between (Pc+Ps)
and (PC-Ps) and testing for its deviation fromzero.
In the present instance, r = 0.67P ~ 0.07.
To visualize what this difference means in practice,
it will now be expressed in terms of the number of
patients required, if smear examination alone is
undertaken, to attain the same amount of discrimina-
tion between regimens as is obtained with 100
patients assessed by culture examination. For this
purpose, an unfavourable response was scored as 0,
a favourable response as 1, and analyses of variance
undertaken (Table 8).
The variance ratio measures the differences in
mean efficacy between regimens, relative to varia-
tions in response between patients receiving the
same regimen. Obviously, the larger the variance
ratio, the greater is the discrimination between the
regimens. It is seen from Table 8 that the variance
ratio obtained from smear results (14.05) is smaller
than that from culture results (16.62). Using com-
ponent analysis (Snedecor, 1956), it is found that
a 20% increase in the number of patients would
result in an increase in the variance ratio for smear
results from 14.05 to 16.62.
It may be concluded that the ability to detect
differences in efficacy between various antituber-
culosis regimens is less with smear examination than
with ulture examination and that this difference
borders on statistical significance (P ~ 0.07), but
can usually be compensated for by an increase of
about 20% in the number of patients admitted to
study.
TABLE 8
ANALYSES OF VARIANCE FOR DATA IN TABLE 7
Classification based on culture resultsClassification based on smear
Sum
of squares
19.1747
153.4643
172.6390
Mean
quare
2.7392
0.1648
16.62
Sum
of squares
15.8354
149.9366
165.7720
Mean
quare
Variance
2.2622 14.05
0.1610
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